Showing 9071-9080 of 19239 results for "".
- Intelectin-2 Strengthens Mucosal Defense and Shows Activity Against Resistant Bacteriahttps://reachmd.com/news/intelectin2-mucosal-defense-resistant-bacteria/2486091/In a new study in Nature Communications, intelectin-2 is described as a gut lectin that recognizes the sugar galactose on mucins and
- LaserAway Introduces Three New Services Across Its Clinic Networkhttps://reachmd.com/news/laseraway-introduces-three-new-services-across-its-clinic-network/2486088/LaserAway announced the launch of 3 new services across its clinic network: the Salmon DNA Facial, XTherma, and an expanded portfolio of LaserAway Wellness Injections. The company said the additions reflect continued investment in science-backed treatments and its medical-first approach to expand
- EMR-Derived ML Flags for Intimate Partner Violence: Radiology Operational Considerationshttps://reachmd.com/news/emr-derived-ml-flags-for-intimate-partner-violence-radiology-operational-considerations/2486075/A machine-learning approach using electronic medical record (EMR) data was reported to flag future intimate partner violence (IPV) risk years
- Review: Dermoscopic Patterns May Improve Differentiation of Acral Melanoma and Nevihttps://reachmd.com/news/review-dermoscopic-patterns-may-improve-differentiation-of-acral-melanoma-and-nevi/2486062/A systematic review and meta-analysis in JAMA Dermatology provides updated evidence on dermoscopic features that differentiate acral lentiginous melanoma (ALM) from benign acral nevi. Investigators searched Embase, P
- Gaps Between Expectations and Reality for an Intraoperative AI Interventionhttps://reachmd.com/news/gaps-between-expectations-and-reality-for-an-intraoperative-ai-intervention/2486054/A recent article conducted a multisite qualitative implementation assessment of the Operating Room Black Box, focusing on gaps between what surgeons expected an intraoper
- Perioperative Considerations and Cellular Immunotherapy Developments in Breast Cancerhttps://reachmd.com/news/perioperative-considerations-and-cellular-immunotherapy-developments-in-breast-cancer/2486060/A recent review summarizes evidence for immune checkpoint inhibitors (ICIs) in breast cancer, highlighting the most consistent clinical benefit in triple-negative breast cancer (TNBC), particularly with chemotherapy, alongside discussion of resistance mechanisms, translational biomarkers, a
- NFAT-Driven uNK Residency Switch Linked to Implantation and Preeclampsiahttps://reachmd.com/news/nfat-driven-unk-residency-switch-linked-to-implantation-and-preeclampsia/2486059/Investigators recently reported on an NFAT-driven “residency” switch in uterine natural killer (uNK) cells, framing NFAT signaling as a regulator of whether these cells adopt and
- Animal Models for Swine Influenza: Model Roles, Limits, and Surveillance Implicationshttps://reachmd.com/news/animal-models-for-swine-influenza-model-roles-limits-and-surveillance-implications/2486032/A recent review of swine influenza animal models describes how experimental readouts can shift depending on whether studies are conducted in mice, ferrets, guinea pigs, pigs, or non-human primate
- INTEGUMENT-OLE Data Show Sustained Efficacy of Roflumilast in Early Childhood ADhttps://reachmd.com/news/integument-ole-data-show-sustained-efficacy-of-roflumilast-in-early-childhood-ad/2486045/The 56-week phase 3 open-label extension for the INTEGUMENT trial (INTEGUMETN-OLE) indicated once-daily roflumilast cream 0.05% maintained efficacy and demonstrated favorable long-term safety in children aged 2 to 5 years with mild-to-moderate atopic dermatitis (AD
- Sotyktu Gets FDA Nod as First TYK2 Inhibitor for Psoriatic Arthritishttps://reachmd.com/news/sotyktu-gains-fda-approval-as-first-tyk2-inhibitor-for-psoriatic-arthritis/2486046/The US Food and Drug Administration (FDA) has approved deucravacitinib (Sotyktu; Bristol Myers Squibb) for the treatment of adults with active psoriatic arthritis (PsA), representing the first oral therapy in its class approved for the treatment of the condition, a